Wednesday, August 29, 2007

Elixir moves diabetes drug into Phase 3 trials

According to an article on diabetes medicine clinical trials, Elixir Pharmaceuticals Inc. has initiated a Phase 3 clinical trial of its drug for type 2 diabetes, officials report.

The Cambridge-based biotech reports its drug, mitiglinide, is designed to help diabetics control their blood sugar and assist them in producing insulin. Company officials said they hope to seek approval of the drug from the U.S. Food and Drug Administration somtime during 2009.

The Phase 3 study involves 300 patients at 50 sites in the United States, according to the company. The trial is expected to conclude in the middle of 2008.

If you have type 2 diabetes and you're on Medicare, you may qualify for a free glucose meter. Visit American Diabetes Services to find out.

No comments: